Nonadherence in difficult asthma – facts, myths, and a time to act

Abstract

Nonadherence to prescribed treatment is an important cause of difficult asthma. Rates of nonadherence amongst asthmatic patients have been shown to range between 30% and 70%. This is associated with poor health care outcomes and increased health care costs. There is no such thing as a “typical” nonadherent patient. The reasons driving nonadherence are multifactorial. Furthermore, adherence is a variable behavior and not a trait characteristic. Adherence rates can vary between the same individual across treatments for different conditions. There is no consistent link between socioeconomic status and nonadherence, and although some studies have shown that nonadherence is more common amongst females, this is not a universal finding. The commonly held perception that better adherence is driven by greater disease severity has been demonstrated to not be the case, in both pediatric and adult patients. Identification of nonadherence is the first step. If adherence is not checked, it is likely that poor adherence will be labeled as refractory disease. Failure to identify poor adherence may lead to inappropriate escalation of therapy, including the potential introduction of complex biological therapies. Surrogate measures, such as prescription counting, are not infallible. Nonadherence can be difficult to identify in clinical practice, and a systematic approach using a variety of tools is required. Nonadherence can be successfully addressed. Therefore, assessment of adherence is of paramount importance in difficult asthma management, in order to reduce exacerbations and steroid-related side effects as well as hospital and intensive care admissions, health care cost, and inappropriate treatment escalation. In this paper, we present an overview of the literature surrounding nonadherence in difficult asthma. We explore the facts and myths surrounding the factors driving nonadherence as well as how it can be identified and addressed.

Mobile Technology Interventions for Asthma Self-Management: Systematic Review and Meta-Analysis

“…Action plans are associated with improved clinical outcomes through incorporation of appropriate education, self-monitoring of symptoms and medication use, and review of symptoms by the individual between physician visits [4]. In more severe patients, daily preventer treatment is associated with a reduced risk of death, as well as asthma exacerbations, thus requiring hospitalization or oral steroid with their related side effects [5,6]. …”

‘All those things together made me retire’: qualitative study on early retirement among Dutch employees

“…The increasing ratio of retired persons to the working age population puts pressure on the social security systems in many European countries [4]. For example, in the Netherlands it is estimated that the costs of the General Old Age Pension Act (AOW) will increase from the current 27 billion euros to 47 billion euros in 2040 [5]. Thus, there is a societal need for workers to extend working life.…”

Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapy

“…Nonadherence to treatment is associated with poor baseline asthma control 48,49. The nonadherence rates among asthmatic patients range between 30% and 70%, and because of this the assessment of medication adherence is a critical part of evaluating the difficult to treat asthma patient 50,51. Integrated and innovative approaches to patients are needed to improve medication adherence in difficult asthmatic patients 52.…”